Coronary slow flow--prevalence and clinical correlations. 2012

Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
Section of Cardiovascular Disease, Department of Internal Medicine, University of Oklahoma Health Sciences Center and Department of Veterans Affairs Medical Center, Oklahoma City, OK, USA.

BACKGROUND Coronary slow flow phenomenon (CSFP) is defined as delayed coronary opacification in the absence of obstructive coronary artery disease. In the present study, we sought to define its prevalence and clinical features. RESULTS The 1,741 consecutive patients who underwent coronary angiography (CAG) were identified. Those with normal left ventricular ejection fraction and normal coronary arteries were included in the study (n=158). TIMI frame counts were calculated, and data on demographics, comorbidities, and medication use were collected. CSFP was defined as frame count > 27. Multivariate logistic regression analysis was used to identify independent predictors of CSFP. CSFP was identified in 96 (5.5%) subjects referred for CAG. Subjects with CSFP were more obese (body mass index [BMI] 33.9 vs. 29.8 kg/m², P=0.003) and had lower high-density lipoprotein levels (39.7 vs. 45.7 mg/dl, P=0.04). In the CSFP group, total cholesterol, low-density lipoprotein and frame counts increased significantly with increasing vessel involvement (1-, vs. 2-, vs. 3-vessel involvement; P<0.05 for each variable). By multivariate analysis, male sex (odds ratio 3.36, 95% confidence interval 1.17-8.61, P=0.02) and higher BMI independently predicted the presence of CSFP (odds ratio 1.09, 95% confidence interval 1.03-1.15, P=0.003). CONCLUSIONS CSFP is associated with male sex and obesity. Multivessel involvement may be a marker of more severe, diffuse disease. Further studies are needed to investigate this hypothesis.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D009825 Oklahoma State bounded on the north by Kansas, on the east by Missouri and Arkansas, on the south by Texas, and on the west by New Mexico.
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D005260 Female Females
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations

Related Publications

Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
February 2016, Research in cardiovascular medicine,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
February 2022, European cardiology,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
March 2013, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
September 2003, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
April 2016, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
April 1977, Arquivos brasileiros de cardiologia,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
June 2022, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
April 2009, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
October 2008, Acta cardiologica,
Beau M Hawkins, and Stavros Stavrakis, and Talla A Rousan, and Mazen Abu-Fadel, and Eliot Schechter
January 2017, Perfusion,
Copied contents to your clipboard!